Acute AppendicitisNCT06624215
Retrospective Acute Care Appendectomy Study
An observational study of Acute Appendicitis, run by Intuitive Surgical at 3 sites in United States.
Trial summary
The purpose of this retrospective study is to compare perioperative data for subjects who have undergone an emergent or urgent robotic-assisted or laparoscopic appendectomy for acute appendicitis. Read more about this study
- Who is it for?
- Ages 22 years and older
- Conditions the study is for
- Acute Appendicitis
- What is being tested?
- Appendectomy
- Type of treatment
- Surgery or procedure
- How many people
- 1,000 participants
- Where
- 3 sitesUnited States
- Study dates
- 22 Nov 2024to 31 Jan 2027
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 22 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Approximately 500 patients who have undergone laparoscopic emergent or urgent appendectomies and approximately 500 patients who have undergone robotic-assisted emergent or urgent appendectomies for acute appendicitis in a reverse chronological order from 30 days prior to IRB approval going back to 2018, will be included in this study.
Who may be able to join
- Subject is 22 years of age or older at time of procedure
- Subject has undergone robotic-assisted or laparoscopic emergent or urgent appendectomy for acute appendicitis between 2018 and 30 days prior to IRB approval
Who cannot join
- Subject with appendiceal neoplasms
- Subject who underwent a single-port appendectomy
- Subject who was pregnant or breastfeeding at the time of the procedure
Trial locations and contacts
3 sites in 1 country.
United States3 sites
The Ohio State University
Columbus, Ohio, 43210
Christus Santa Rosa Health Care Corporation
New Braunfels, Texas, 78130
Legacy Emanuel Hospital & Health Center
Portland, Oregon, 97232
About this study
Official title: A Retrospective Multicenter Evaluation of Short-Term Outcomes After Acute Care Appendectomy
The purpose of this retrospective study is to compare perioperative data for subjects who have undergone an emergent or urgent robotic-assisted or laparoscopic appendectomy for acute appendicitis.
- Conditions
- Acute Appendicitis
- Being tested
- Appendectomy
- Keywords
- Appendectomy, Robotic-assisted, Acute care, Laparoscopic
- Medical subject headings
- Appendicitis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AppendectomyProcedure or surgery
Robotic-assisted or laparoscopic appendectomy for acute appendicitis.
| Study group | Role | What they receive |
|---|---|---|
| Robotic-assisted appendectomy subjects | Approximately 500 subjects will be enrolled in this group who have undergone an emergent or urgent robotic-assisted appendectomy for acute appendicitis in a reverse chronological order from 30 days prior to IRB approval going back to 2018. Receives: Procedure: Appendectomy | |
| Laparoscopic appendectomy subjects | Approximately 500 subjects will be enrolled in this group who have undergone an emergent or urgent laparoscopic appendectomy for acute appendicitis in a reverse chronological order from 30 days prior to IRB approval going back to 2018. Receives: Procedure: Appendectomy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Operative time
Measured: Intraoperative
Procedure time
Measured: Intraoperative
Conversion
Measured: Intraoperative
Adverse events
Measured: Intraoperative and postoperative out to 30 days from procedure date
Mortality rate through 30 days
All cause
Measured: Intraoperative and postoperative out to 30 days from procedure date
Unplanned procedure-related readmission rate through 30 days
Measured: Discharge through 30 days
Concomitant procedures
Measured: Intraoperative
Estimated blood loss
Measured: Intraoperative
Severity of appendicitis
Measured: Preoperative
Unplanned procedure-related reoperation rate through 30 days
Measured: Postoperative through 30 days
Length of stay
Total number of days the subject stayed in the hospital after the index procedure prior to being discharged.
Measured: Start of procedure to discharge from the hospital (check-out time), up to approximately one week
Discharge disposition
Where the subject was discharged to when released from the hospital
Measured: Discharge from the hospital (check-out time), up to approximately one week.
Blood Transfusion
Any occurrence of blood transfusion either at the time of the procedure or at any point during the post-procedure hospitalization until the participant is discharged.
Measured: Intraoperative and discharge from the hospital (check-out time), up to approximately one week.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Oct 2024
- Study start22 Nov 2024
- Primary completion31 Oct 2025
- Study completion31 Jan 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Acute AppendicitisStudies of the same condition, open and under way.
- More trials run by Intuitive SurgicalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 1,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Intuitive Surgical
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06624215
- Sponsor's protocol ID
- ISI MP-APP-01
- Status last verified
- Sep 2026
- First submitted
- 3 Sep 2024
- Last updated
- 24 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No